Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

November 30, 2004

Conditions

Prediabetic State

Interventions

DIETARY_SUPPLEMENT

Vanadyl sulfate

50 mg twice daily orally for a period of 4 weeks

OTHER

Magnesium oxide

Validation of similar appearance and weight to the intervention component orally 1 unit (\<50 mg) twice daily for a period of 4 weeks

Trial Locations (1)

Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente, Guadalajara

All Listed Sponsors

collaborator

Fondo para el Fomento a la Investigacion Medica

UNKNOWN

collaborator

Doctorado en Farmacologia de la Universidad de Guadalajara

UNKNOWN

lead

Unidad de Investigacion Medica en Epidemiologia Clinica

OTHER

NCT00561132 - Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance | Biotech Hunter | Biotech Hunter